These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
387 related items for PubMed ID: 15676220
1. A possible association between the presence of interleukin-4-secreting cells and a reduction in the risk of acute graft-versus-host disease. Takabayashi M, Kanamori H, Takasaki H, Yamaji S, Koharazawa H, Taguchi J, Tomita N, Fujimaki K, Fujisawa S, Maruta A, Ishigatsubo Y. Exp Hematol; 2005 Feb; 33(2):251-7. PubMed ID: 15676220 [Abstract] [Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL. Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [Abstract] [Full Text] [Related]
3. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease. Szebeni J, Wang MG, Pearson DA, Szot GL, Sykes M. Transplantation; 1994 Dec 27; 58(12):1385-93. PubMed ID: 7809932 [Abstract] [Full Text] [Related]
5. Role of interleukin-12 in the development of acute graft-versus-host disease in bone marrow transplant patients. Yabe M, Yabe H, Hattori K, Shimizu T, Matsumoto M, Morimoto T, Yasuda Y, Inoue H, Kato S, Nishimura T. Bone Marrow Transplant; 1999 Jul 27; 24(1):29-34. PubMed ID: 10435731 [Abstract] [Full Text] [Related]
6. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation. Dander E, Balduzzi A, Zappa G, Lucchini G, Perseghin P, Andrè V, Todisco E, Rahal D, Migliavacca M, Longoni D, Solinas G, Villa A, Berti E, Mina PD, Parma M, Allavena P, Biagi E, Rovelli A, Biondi A, D'Amico G. Transplantation; 2009 Dec 15; 88(11):1261-72. PubMed ID: 19996925 [Abstract] [Full Text] [Related]
7. Cytokine gene expression by concanavalin A-stimulated peripheral mononuclear cells after bone marrow transplantation: an indicator of immunological abnormality due to chronic graft-versus-host disease. Tanaka J, Imamura M, Kasai M, Zhu X, Kobayashi S, Imai K, Hashino S, Higa T, Sakurada K, Miyazaki T. Bone Marrow Transplant; 1994 Nov 15; 14(5):695-701. PubMed ID: 7889002 [Abstract] [Full Text] [Related]
8. Immunomonitoring of graft-versus-host minor histocompatibility antigen correlates with graft-versus-host disease and absence of relapse after graft. Laurin D, Hannani D, Pernollet M, Moine A, Plumas J, Bensa JC, Cahn JY, Garban F. Transfusion; 2010 Feb 15; 50(2):418-28. PubMed ID: 19843288 [Abstract] [Full Text] [Related]
9. Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease. Imoto S, Oomoto Y, Murata K, Das H, Murayama T, Kajimoto K, Sugimoto T, Gomyo H, Nakagawa T, Nishimura R, Koizumi T. Int J Hematol; 2000 Jul 15; 72(1):92-7. PubMed ID: 10979216 [Abstract] [Full Text] [Related]
16. The effects of interleukin 10 and interferon gamma cytokine gene polymorphisms on survival after autologous bone marrow transplantation for patients with breast cancer. Wu JM, Bensen-Kennedy D, Miura Y, Thoburn CJ, Armstrong D, Vogelsang GB, Hess AD. Biol Blood Marrow Transplant; 2005 Jun 15; 11(6):455-64. PubMed ID: 15931634 [Abstract] [Full Text] [Related]
18. Time course of interferon-gamma production deficiency after autologous and allogeneic stem cell transplantation for malignancies. Hanenberg H, Dilloo D, Laws HJ, Zessack N, Heyll A, Burdach S. Exp Hematol; 1995 Dec 15; 23(14):1543-52. PubMed ID: 8542945 [Abstract] [Full Text] [Related]
20. Production of IL-10 by alloreactive sibling donor cells and its influence on the development of acute GVHD. Weston LE, Geczy AF, Briscoe H. Bone Marrow Transplant; 2006 Jan 15; 37(2):207-12. PubMed ID: 16284610 [Abstract] [Full Text] [Related] Page: [Next] [New Search]